Funding for this research was provided by:
Fundación Nutrición y Crecimiento
Fondo de Investigaciones Sanitarias
Kyowa Kirin Farmacéutica S.L.U.
Received: 25 June 2020
Accepted: 3 February 2021
First Online: 27 February 2021
Change Date: 1 April 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/S13023-021-01786-5
Ethics approval and consent to participate
: Patients information has been processed via RenalTube database where patients signed their consent to participate in scientific studies.
: Patients or parents signed consent for publication of their data through RenalTube consent form.
: The study has been partially funded by Kyowa Kirin Farmacéutica S.L.U. This company produces the drug Crysvita® (burosumab). Nevertheless, no patients in this study had been or were being treated with burosumab at the time of data collection.